Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 159 | 1 | 187 | +29 |
| Shares | 48.9M | 67.5K | 50.3M | +1.40M (+2.9%) |
| Value | $1.55B | $2.13M | $1.48B | −$59.6M (−3.9%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (16)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| NEA Management Company, LLC | 2,186,243 | $69.1M |
| Sphera Funds Management Ltd. | 114,284 | $3.61M |
| Soleus Capital Management, L.P. | 103,000 | $3.25M |
| Parkman Healthcare Partners LLC | 65,050 | $2.06M |
| HRT Financial LP | 29,097 | $919.0K |
| Schonfeld Strategic Advisors LLC | 21,799 | $688.8K |
| Verition Fund Management LLC | 19,400 | $613.0K |
| Tudor Investment Corp Et Al | 19,104 | $603.7K |
| Balyasny Asset Management LLC | 18,107 | $572.2K |
| Quantbot Technologies LP | 12,069 | $381.4K |
| Virtus Investment Advisers, Inc. | 6,361 | $201.0K |
| Aquatic Capital Management LLC | 3,900 | $123.0K |
| Group One Trading, L.P. | 1,527 | $48.3K |
| Virtus Fund Advisers, LLC | 1,069 | $33.8K |
| Oliver Lagore Vanvalin Investment Group | 162 | $5.12K |
| Paladin Advisory Group, LLC | 131 | $4.14K |
Not filed for Q4 2023 yet (1)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 67,500 | $2.13M |